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Pain is a global health problem that impairs life quality. The rapid advancement in drug study 
is still relying on herbal plants as the source for bioactive compounds. First documented by 
Nicolaas Laurens Burman in 1984, Belalai gajah (Clinacanthus nutans Lindau) is a herbal 
plant from Acanthaceae family that is well-known in Asia as a herbal remedy for snake 
bites, herpes infection, skin infection, cancer, dysentery and diabetes. In recent years, 
phytochemical screening of C. nutans revealed the presence of bioactive metabolites 
which potentially contributes to its antiviral, antimicrobial, antioxidant and anti-
inflammatory properties as reported in previous studies. However, it is difficult to 
determine the safe dosage of C. nutans when it is used in different ways. Much of the studies 
were conducted through in vivo method which provided little information on biomolecular 
interaction. Therefore, this study aimed to extract, isolate and elucidate compounds from C. 
nutans. The potential of C. nutans phytochemicals as analgesic was assessed via ligand-
based and structure-based pharmacophore modelling. Antioxidant assay, toxicity assay and 
analgesic assay of extracts, partitions and isolated compounds of C. nutans were conducted 
in this study. C. nutans leaves was extracted and proceeded to compound isolation using 
column chromatography technique. Using spectroscopy technique, three compounds were 
elucidated as 3,7,11,15-tetramethyl-2-hexadecen-1-ol, (2S)-1-O-linolenoyl-3-O-β-D-
galactopyranosyl glycerol and 8-β-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-
4H-1-benzopyran-4-one. These compounds were described as EA-1, EA-2 and MEOH-1, 
respectively. Pharmacophore analysis of isolated and reported compounds were conducted 
using LigandScout 4.2 software. Pharmacophore model was generated from training set 
comprised of analgesic drugs. Test set was aligned to pharmacophore model to obtain fit 
value and common pharmacophore features. Crystal structure of cyclooxygenase-2 (COX-
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2) with bound ibuprofen was the selected target complex. The interaction of test set to amino 
acid residue in binding site and score were obtained.  2,2-diphenyl-1-picrylhydrazyl (DPPH) 
antioxidant, toxicity and in vivo analgesic assay were conducted to evaluate biological 
activity of extract and isolated compounds. Pharmacophore analysis showed MEOH-1 and 
EA-2 had good fit value (53.59, 52.85), five interactions with pharmacophore model but EA-
1 was scored low (43.64). Isoorientin and isovitexin were scored best with six 
pharmacophore interactions compared to other test set. MEOH-1 had better alignment score 
to COX-2 active site than EA-1 and EA-2 with value 45.45, 45.36 and 40.18, respectively. 
Orientin and isomollupentin scored the best among all test set. MEOH-1 satisfied all 
Lipinski’s parameter, while EA-2 and EA-1 did not satisfy molecular weight and Log P 
value. MeOH partition had the best antioxidant activity of IC50 15.73 µg/mL while MEOH-
1 was IC50 19.27 µg/mL. C. nutans was concluded to be less toxic (LC50 < 1000 µg/mL) with 
hexane partition had the highest LC50 value of 128.4 µg/mL. LD50 of extracts and all 
partitions were determined to be greater than 2000 mg/kg and classified closely to Category 
5. Both analgesic tests revealed MeOH extract to have better capability to prolong latency 
response than partitions but did not show significant analgesic effect as compared to 
ibuprofen (p<0.05) at concentration 200 mg/kg. To conclude, C. nutans leaves extract had 
mild analgesic effect, possess bioactive compounds suitable as analgesic agent based on 
pharmacophore interaction and in vivo assay. C. nutans extracts and partitions are not toxic, 
and safe for consumption.  
Keywords: Belalai gajah, Clinacanthus nutans, Nicolaas Laurens Burman, 
pharmacophore analysis, antioxidant, analgesic agent, spectroscopy technique, 




Kajian Fitokimia ke atas Belalai Gajah (Clinacanthus nutans Lindau) sebagai Agen 
Analgesik Melalui Analisa Farmakofor dan Kaedah Biologi 
ABSTRAK 
Rasa sakit ialah masalah kesihatan global yang menjejaskan kualiti kehidupan. 
Perkembangan pesat kajian perubatan masih bergantung kepada tumbuhan herba sebagai 
sumber sebatian aktif. Pertama kali didokumenkan oleh Nicolaas Laurens Burman pada 
tahun 1984, belalai gajah (Clinacanthus nutans Lindau) adalah tumbuhan daripada 
keluarga Acanthaceae yang terkenal di Asia sebagai herba untuk gigitan ular, jangkitan 
herpes dan kulit, kanser, keradangan perut dan diabetes. Penyaringan fitokimia C. nutans 
menunjukkan potensi metabolit aktif terhadap sifat antiviral, antimikrobial, antioksida dan 
anti-radang. Namun, dos selamat untuk C. nutans sukar ditentukan kerana perbezaan cara 
penggunaan. Terdahulu, kajian in vivo kekurangan maklumat berkenaan interaksi 
biomolekul. Kajian ini bertujuan untuk mengekstrak, menulen dan mengenal pasti sebatian 
dari C. nutans.  Potensi analgesik fitokimia ditentukan melalui analisa farmakofor 
berdasarkan ligan dan struktur. Kajian antioksida, toksisiti dan analgesik dilakukan pada 
ekstrak, fraksi dan sebatian tulen dari C. nutans. Daun C. nutans telah diekstrak dan melalui 
penulenan sebatian menggunakan teknik kromatografi. Melalui teknik spektroskopi, tiga 
sebatian tulen telah dikenalpasti sebagai 3,7,11,15-tetramethyl-2-hexadecen-1-ol, (2S)-1-O-
linolenoyl-3-O-β-D-galactopyranosyl glycerol, dan 8-β-D-glucopyranosyl-5,7-dihydroxy-2-
(4-hydroxyphenyl)-4H-1-benzopyran-4-one. Sebatian tulen ini dijelaskan sebagai EA-1, EA-
2 dan MEOH-1. Analisa farmakofor sebatian tulen dan yang pernah dilaporkan dilakukan 
menggunakan perisian LigandScout 4.2. Model farmakofor dijana menggunakan set 
cadangan yang terdiri daripada ubat analgesik. Set ujian diselaraskan pada model 
farmakofor untuk mendapatkan nilai kesesuaian dan persamaan sifat farmakofor. Struktur 
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kristal cyclooxygenase-2 (COX-2) dengan ikatan ibuprofen adalah kompleks sasaran. 
Interaksi set ujian dengan asid amino di dalam tapak ikatan dan skor kelarasan telah 
diperoleh. Ujian antioksida 2,2-diphenyl-1-picrylhydrazyl (DPPH), ujian toksisiti, dan ujian 
analgesik in vivo dilakukan untuk menilai kesan biologi dari ekstrak dan sebatian tulen. 
Analisa farmakofor menunjukkan MEOH-1 dan EA-2 mempunyai nilai kesesuaian bagus 
(53.59, 52.85), lima interaksi terhadap model farmakofor tetapi EA-1 mempunyai nilai 
kesesuaian rendah (43.64). Isoorientin dan isovitexin mempunyai nilai kesesuaian terbaik 
dan enam interaksi berbanding yang lain. MEOH-1 mempunyai skor keselarasan lebih baik 
terhadap tapak ikatan COX-2 berbanding EA-2 dan EA-1 dengan nilai 45.45, 45.36 dan 
40.18 masing-masingnya. Orientin dan isomollupentin mempunyai nilai keselarasan terbaik 
berbanding yang lain. MEOH-1 melepasi semua parameter Lipinski, sementara EA-2 dan 
EA-1 tidak melepasi parameter berat molekul dan nilai Log P. Fraksi metanol mempunyai 
aktiviti antioksida terbaik iaitu IC50 15.73 µg/mL manakala MEOH-1 ialah IC50 19.27 
µg/mL. C. nutans dikenalpasti sebagai kurang toksik (LC50 < 1000 µg/mL) dan fraksi hexana 
mempunyai nilai LC50 tertinggi iaitu 128.4 µg/mL. LD50 ekstrak dan fraksi melebihi 2000 
mg/kg, dikelaskan dalam kategori 5. Kedua-dua ujian analgesik menunjukkan ekstrak 
metanol mampu memanjangkan kesan latensi berbanding fraksi tetapi tiada kesan analgesik 
yang ketara berbanding ibuprofen (p<0.05) pada 200mg/kg. Kesimpulannya, ekstrak daun 
C. nutans mempunyai kesan analgesik yang sederhana, mempunyai sebatian aktif sesuai 
sebagai agen analgesik berdasarkan interaksi farmakofor dan kajian in vivo. Ekstrak dan 
fraksi dari C. nutans adalah tidak toksik dan selamat untuk pemakanan. 
Kata kunci: Belalai gajah, Clinacanthus nutans, Nicolaas Laurens Burman, analisa 
farmakofor, antioksida, agen analgesik, teknik spektroskopi, teknik kromatografi 
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1.1 Background of the Research 
  Plant has been a great source of medicine since the early time from the medicine 
records of Chinese, Hindu and Mediterranean civilization. Belalai gajah (Clinacanthus 
nutans Lindau) is one of well recognized herbs from Acanthaceae family commonly found 
in Southeast Asia countries, where it thrives in tropical climate and grows well in the wild 
(Fongod et al., 2013). The first record of C. nutans was by a dutch botanist named Nicolaas 
Laurens Burman dated back to 1894. He recorded the specimen as Clinacanthus nutans 
(Burm. f.) Lindau, which was later accepted as the species name by the International Plant 
Names Index in 1899  (Kamarudin et al., 2017).   
Leaves is the only part of C. nutans that is utilized as herbs. Traditionally, it is 
consumed as tea, juice or ulam as it is believed to cure diabetes, cancer and gout. It is used 
as poultice to relieve skin inflammation due to rashes, lesion and burns, insects and snake 
bites. Nowadays, it is commercialized as health products in the form of cream for topical 
application and capsules especially in Thailand. In recent years, several pharmacological 
properties of C. nutans have been tested based on the therapeutic claims and some interesting 
findings were highlighted. The anti-inflammatory response was found to be dose dependent 
by inhibiting elastase and proinflammatory cytokines release in mice (Thongrakard & 
Tencomnao, 2010; Wanikiat et al., 2008). The antiviral property is associated with its 
moderate activity against dengue virus type-2 and inhibition of late stage herpex simplex 
virus multiplication using alcoholic extract, containing monogalactosyl and digalactosyl 
diglyceride (Yong et al., 2013). The aqueous extract is potentially an antidiabetic as it was 
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found to inhibit α-glucosidase at 88 % activity (50 mg/mL) (Wong et al., 2014). Also, 
anticancer activity was observed against cervical cancer cells and melanoma cells (Fong et 
al., 2016; Yong et al., 2013). C. nutans extract was suggested to be an effective 
complementary approach for cancer prevention and treatment as it exerted antitumor and 
antioxidant activity against mouse model with no toxicity effect (Nik et al., 2019). The 
antioxidant activity is most likely due to the presence of flavonoids in the leaves extract. 
Previous studies reported various compounds from C. nutans in the form of steroids, 
triterpenoids, flavonoids, phenolic acid, glycosides and chlorophyll derivative (Irchhaiya et 
al., 2015). 
However, herbal medicine is to be consumed moderately as it may bring adverse 
effect to those suffering chronic diseases. Traditional Chinese medicine highlighted that 
incompatible herbs mixture will impair the overall efficacy of drug prescription. The 
transition of herbs to synthetic drugs was accelerated during world war as there were 
pressing needs for better surgical technique and more effective drug to treat severe infections 
(Dailey, 2018). Pharmaceutical companies were pushed to develop more effective drugs at 
industrial scale. Despite this, isolated active compounds from herbs are still useful as lead 
compounds and have been modified into derivatives to improve their side effects.  
1.2 Analgesic Agent Discovery 
Opioids and non-steroidal anti-inflammation drugs have remained as the main 
treatment in chronic pain. The development of analgesics for acute and chronic pain relieve 
is an ongoing discovery since pain is a pervasive health problem related to cancer, 
inflammation and nervous system injury (Decosterd & Woolf, 2000). The four largest causes 
of pain are cancer, arthritis, operations and injuries, and spinal problems, making the etiology 
of pain a complex, transdisciplinary affair (Goldberg & McGee, 2011). Following these 
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years, drug development research is driven by advanced instruments, databank resources 
available online and in silico approach which complements in vivo approach.  
Pharmacophore modelling is one of computer-aided approach to enable study of 
compound interaction with or without 3-dimensional (3D) macromolecular target. Softwares 
are developed with multilevel search filter to assist in screening of bioactive compounds.  
Pharmacophore application is becoming the main tool in drug discover as its application 
been extended to lead optimization, evaluate pharmacokinetic properties and optimize 
derivatives based on structural information (Thiel, 2004).  
1.3 Problem Statement 
The analgesic drugs could be useful over wide range of conditions but they are not 
uniformly effective and may cause adverse effects due to long consumption. Consequently, 
the ongoing drug discovery focus is to find novel analgesics with improved properties. 
Traditional medicine is easily obtained from nature but its long-term use could not be easily 
assessed without much understanding of the active components. The study of medicinal plant 
incorporated with in silico method is still uncommon. Through chromatography technique, 
isolation of pure compounds could be achieved with the use of suitable solvent and 
monitored by thin layer chromatography. In silico method using pharmacophore modelling 
allows the bioactivity of C. nutans compounds to be assessed at biomolecular level. It 
provides analysis from wider spectrum, faster time and to support findings from in vivo test. 
The existing studies of C. nutans has been mainly on antioxidant and anti-cancer properties. 
Thus, the study of its analgesic effect could further increase the medicinal value of C. nutans 
without overlooking the risk of its toxicity.  
